Literature DB >> 10860940

Scanning mutagenesis identifies amino acid side chains in transmembrane domain 5 of the M(1) muscarinic receptor that participate in binding the acetyl methyl group of acetylcholine.

K Allman1, K M Page, C A Curtis, E C Hulme.   

Abstract

The exofacial part of transmembrane domain 5 (TMD 5) of the cationic amine-binding subclass of 7-transmembrane receptors is thought to be important in binding the side chain of the agonist. Residues Ile-188 through Ala-196 in TMD 5 of the M(1) muscarinic acetylcholine receptor (mAChR) have been studied by Cys- and Ala-scanning mutagenesis. The results are consistent with a helical conformation for this sequence. The positively charged sulfhydryl reagent N-trimethyl-2-aminoethyl methanethiosulfonate reacted selectively with Phe-190 --> Cys, Thr-192 --> Cys, and Ala-193 --> Cys, indicating that the face of TMD 5 accessible from the binding site crevice is consistent with a recent model by Baldwin and colleagues of the transmembrane domain of the 7-transmembrane receptors. In contrast, the acetylcholine derivative bromoacetylcholine reacted selectively with Thr-192 --> Cys, which forms the focus of a group of amino acids (Ile-188, Thr-189, Thr-192, Ala-196) whose mutation decreased the binding affinity of the transmitter ACh itself. The center of this patch of residues is offset to one side of the binding pocket, suggesting that a rotation of TMD 5, relative to that implied by the Baldwin model, may be necessary to optimize the anchoring of acetylcholine within the binding site of the M(1) mAChR. An induced rotation of TMD 5 could contribute to the formation of the activated state of the receptor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10860940     DOI: 10.1124/mol.58.1.175

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

Review 1.  Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.

Authors:  Gregory J Digby; Jana K Shirey; P Jeffrey Conn
Journal:  Mol Biosyst       Date:  2010-06-25

2.  Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias.

Authors:  Karen J Gregory; Nathan E Hall; Andrew B Tobin; Patrick M Sexton; Arthur Christopoulos
Journal:  J Biol Chem       Date:  2010-01-05       Impact factor: 5.157

3.  Principal component analysis of binding energies for single-point mutants of hT2R16 bound to an agonist correlate with experimental mutant cell response.

Authors:  Derek E Chen; Darryl L Willick; Joseph B Ruckel; Wely B Floriano
Journal:  J Comput Biol       Date:  2015-01       Impact factor: 1.479

4.  Functional rescue of beta-adrenoceptor dimerization and trafficking by pharmacological chaperones.

Authors:  Hiroyuki Kobayashi; Koji Ogawa; Rong Yao; Olivier Lichtarge; Michel Bouvier
Journal:  Traffic       Date:  2009-06-09       Impact factor: 6.215

Review 5.  Novel designer receptors to probe GPCR signaling and physiology.

Authors:  Jürgen Wess; Kenichiro Nakajima; Shalini Jain
Journal:  Trends Pharmacol Sci       Date:  2013-06-13       Impact factor: 14.819

6.  Molecular modeling of the M3 acetylcholine muscarinic receptor and its binding site.

Authors:  Marlet Martinez-Archundia; Arnau Cordomi; Pere Garriga; Juan J Perez
Journal:  J Biomed Biotechnol       Date:  2012-02-27

7.  In Silico and In Vitro Analysis of Bacoside A Aglycones and Its Derivatives as the Constituents Responsible for the Cognitive Effects of Bacopa monnieri.

Authors:  Seetha Ramasamy; Sek Peng Chin; Sri Devi Sukumaran; Michael James Christopher Buckle; Lik Voon Kiew; Lip Yong Chung
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.